Blue Moon Metals is pleased to provide an update on its fully integrated 2026 exploration and resource definition program at the Springer Tungsten Project. Springer is a largely permitted facility ...

Blue Moon Metals Inc. ("Blue Moon" or the "Company") , is pleased to provide an update on its fully integrated 2026 ...

TORONTO, July 7, 2026 /PRNewswire/ - Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM), is pleased to provide an update on its fully integrated 2026 exploration ...

Health Canada, in collaboration with the Federal-Provincial-Territorial Committee on Drinking Water, may choose to develop guidance documents for two reasons. The first is to provide operational or ...

This repository contains the code (simulation and real-world experiments with minimum setup) for the paper "Full-Order Sampling-Based MPC for Torque-Level Locomotion Control via Diffusion-Style ...

Estimates from January to March 2025 include the full effect of the improvements in Labour Force Survey (LFS) data collection and sampling methods introduced from January 2024; however, estimates may ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J. Brock is a CFA and CPA with more ...

Objective Lack of consensus on the definition of mental health has implications for research, policy and practice. This study aims to start an international, interdisciplinary and inclusive dialogue ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Table 1. Proportion of Canadian children 1-8 years with macronutrient intakes below, within or above the Acceptable Macronutrient Distribution Ranges (AMDR) (2004) <3 - Data with a coefficient of ...

bSchool of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, SE1 9RT, UK cDivision of Cancer Epidemiology and Genetics, National Cancer ...

Expenditure on research and development (R&D) performed by UK businesses was £50.0 billion in 2023, an increase of £1.4 billion since 2022 (2.9%). The Pharmaceuticals product group made the largest ...